AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Sep 10, 2012
30016_dirs_2012-09-10_4b7b6bbf-d1b1-466e-af5a-a5510fc7a79c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-09-06
Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-06 | Common Stock | M | 2401 | $77.5900 | Acquired | 8399 | Direct |
| 2012-09-06 | Common Stock | S | 2401 | $98.4522 | Disposed | 5998 | Direct |
| 2012-09-06 | Common Stock | S | 1120 | $98.7100 | Disposed | 4978 | Direct |
| 2012-09-06 | Common Stock | S | 880 | $98.8017 | Disposed | 3998 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-06 | Non-Qualified Stock Option (right to buy) | $77.5900 | M | 2401 | Disposed | 2016-02-14 | Common Stock (2401) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $98.3200 to $98.4950, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on 02/14/2012, 02/14/2013, 02/14/2014, 02/14/2015, and the remaining 1,112 shares on 02/14/2016.